Try our Advanced Search for more refined results
Mergers & Acquisitions
-
December 17, 2025
Warner Bros. Board Rejects 'Inferior' Paramount Bid
Warner Bros. Discovery Inc. said Wednesday that its board has determined Paramount Skydance Corp.'s $108.4 billion hostile offer is not a "superior proposal" to the company's pending $82.7 billion agreement with Netflix.
-
December 17, 2025
Finance Co. Gets Extra Time To Make £523M UK Credit Biz Bid
Britain's merger regulator has extended the deadline of U.S. finance group BasePoint Capital LLC to table a £523 million ($697 million) bid for International Personal Finance PLC, the U.K. credit provider said Wednesday.
-
December 17, 2025
Greencore's £1.2B Bakkavor Deal To Complete After CMA OK
Irish food manufacturer Greencore said Wednesday that it expects its £1.2 billion ($1.6 billion) acquisition of rival Bakkavor to complete in January after the U.K.'s competition authority abandoned its probe amid antitrust fixes proposed by the sides.
-
December 16, 2025
Judge Skeptical Of Trump-Tied SPAC's Defense In SEC Suit
A former Trump business associate appeared unlikely to win early dismissal of a U.S. Securities and Exchange Commission suit accusing him of hiding advanced merger discussions with the president's media company from SPAC investors in 2021, as a federal judge wondered Tuesday how the talks could be considered immaterial.
-
December 16, 2025
Va. Judge Advances Most Claims In Stelara Antitrust Case
A Virginia federal judge has allowed health insurer CareFirst's anticompetition and patent fraud claims against Johnson & Johnson to move forward in a case alleging anticompetitive behavior in relation to the immunosuppressive drug Stelara, while letting the pharmaceutical giant escape some claims of misrepresentation.
-
December 16, 2025
The Most Important Healthcare And Life Science Deals Of 2025
Attorneys taking stock of 2025 spoke to Law360 about the most important deals of the year, including Pfizer’s high-profile acquisition of Metsera and transactions in outpatient services and gene therapy.
-
December 16, 2025
Trends That Shaped Healthcare Dealmaking In 2025
With 2025 coming to a close, Law360 Healthcare Authority asked attorneys focused on healthcare deals for their take on the trends that influenced dealmaking over the last 12 months.
-
December 16, 2025
PE Giant KKR Plugs $220M Into Dubai-Based Premialab
Data, analytics and risk management solutions provider Premialab, advised by A&O Shearman, on Tuesday revealed that it received a $220 million growth investment from Gibson Dunn & Crutcher LLP-led private equity giant KKR.
-
December 16, 2025
JP Morgan PE Group's Latest Fund Exceeds Target At $1.44B
J.P. Morgan Asset Management's private equity group closed its 12th flagship fund, PEG Global Private Equity XII, above its $1.25 billion target at $1.44 billion, the firm announced Tuesday.
-
December 16, 2025
Kering, Ardian Form $900M JV At Luxury NYC Property
French luxury group Kering said Tuesday it has completed another real estate joint venture with private equity firm Ardian, expanding a partnership launched earlier this year with a $900 million deal for a Fifth Avenue retail property in New York City.
-
December 15, 2025
Del. Justices Put ITG On Hook For $250M Reynolds Settlement
Delaware's Supreme Court stubbed out an eight-year ITG Brands LLC legal battle to avoid paying R.J. Reynolds more than $250 million to cover health-related settlement payments to Florida after ITG's acquisition of four of the cigarette company's brands, according to a ruling issued Monday.
-
December 15, 2025
Fast-Track Sale Timeline Denied In Furniture Co. Ch. 11
A Delaware bankruptcy judge rejected an expedited timeline for the sale of the assets of home furnishing retailer American Signature Furniture, finding that the proposed 34-day process would not give enough time for an investigation of insider claims and the appointment of a consumer privacy ombudsman.
-
December 15, 2025
Cencora Pays $5B For Majority Stake Of OneOncology
Pharmaceutical company Cencora Inc. unveiled plans Monday to acquire a majority stake in cancer care company OneOncology for $5 billion, buying interest from private equity shop TPG in a deal built by three law firms.
-
December 15, 2025
Juventus Rejects Crypto Firm Tether's Bid, Stock Soars
The owners of Italian football club Juventus rejected an unsolicited buyout bid from crypto firm Tether, saying there is "no intention" of selling shares and helping to push the club's market capitalization above $1 billion as its stock surged Monday.
-
December 15, 2025
Investment Firms Nab Quipt Home Medical In $260M Deal
Medical equipment provider Quipt Home Medical Corp. on Monday announced plans to go private after being purchased by a special purpose acquisition vehicle funded by investment firms Kingswood Capital Management and Forager Capital Management in a deal that values the company at $260 million and was built by three law firms.
-
December 15, 2025
Catching Up With Delaware's Chancery Court
Litigation in Delaware's Court of Chancery sprawled from a dispute over control of banana plantations along Africa's Congo River to a fight over the late musician Prince's estate last week. Along the way, a court ruling rejected a motion for a quick decision favoring Blue Bell Creameries director and officer calls for liability releases in a tainted ice cream saga that dates to 2015.
-
December 15, 2025
Europe Seen As Top Tech M&A Prospect For 2026
Europe has quietly become tech dealmakers' top hunting ground, as global tech mergers and acquisitions values skyrocketed more than 72% in the first three quarters of the year, according to a new global survey from Morrison Foerster LLP.
-
December 15, 2025
McDermott-Led Sobi To Buy US Gout Specialist For $1.5B
Swedish biopharma company Swedish Orphan Biovitrum AB said Monday that it has agreed to acquire Arthrosi Therapeutics Inc., a specialist in treatment for gout, for up to $1.5 billion in a deal guided by McDermott.
-
December 12, 2025
Live Nation Consumers Get Class Certified In Antitrust Case
A California federal judge Friday certified a class of consumers accusing Live Nation of monopolizing the live entertainment industry, rejecting the company's argument that there aren't common issues that predominate over individual ones and adopting a tentative ruling he issued earlier this month.
-
December 12, 2025
Printing Co. Defends Trial Win In $265M ESOP Sale Dispute
A printing company's directors and employee stock ownership plan trustee say the Seventh Circuit should back their win over accusations they illegally undersold the company into private equity for $265 million, arguing the trial court correctly decided their interests were "perfectly aligned" with plan participants' interests.
-
December 12, 2025
Prospect Medical Wins OK For Chapter 11 Plan
A Texas bankruptcy judge approved Prospect Medical Holdings Inc.'s Chapter 11 plan after overruling a slew of objections during an all-day hearing Friday and allowing the healthcare group to hand off its remaining hospitals and pursue litigation to repay creditors.
-
December 12, 2025
Wrong Metric Created $2 Valuation, Chancery Suit Says
A former equity holder in a nutrition services business has sued in Delaware Chancery Court seeking to unwind what it calls a sham $2 repurchase of its ownership interest and to force payment of a separate $2 million deferred purchase price, arguing that the business disregarded contractually mandated valuation mechanics to engineer a zero-value outcome.
-
December 12, 2025
2 Firms Guide Stake Deal For Data Center Services Company
Middle market private equity firm Kohlberg will obtain a majority stake in industrial services company Loenbro LLC in a deal guided by Kirkland & Ellis LLP and Greenberg Traurig LLP, the companies announced.
-
December 12, 2025
Chancery Lets Nextdoor Argue De-SPAC Suit Filed Too Late
The Delaware Chancery Court on Friday let Nextdoor Inc. and related defendants argue that investors waited too long to sue over the company's de-SPAC merger, while pausing discovery as the court considers motions that could end the case.
-
December 12, 2025
MVP: Wachtell Lipton's Jake Kling
Jake Kling of Wachtell Lipton Rosen & Katz guided Global Payments' $24.25 billion acquisition of Worldpay and the PGA Tour's groundbreaking $3 billion investment from Strategic Sports Group, earning him a spot as one of the 2025 Law360 Mergers & Acquisitions MVPs.
Expert Analysis
-
8 Ways Lawyers Can Protect The Rule Of Law In Their Work
Whether they are concerned with judicial independence, regulatory predictability or client confidence, lawyers can take specific meaningful actions on their own when traditional structures are too slow or too compromised to respond, says Angeli Patel at the Berkeley Center of Law and Business.
-
Assessing New Changes To Texas Officer Exculpation Law
Consistent with Texas' recent modernization of its corporate law, the recently passed S.B. 2411 allows officer exculpation, streamlines certificate of formation amendments, authorizes representatives to act on shareholders' behalf in mergers and makes other changes aimed toward companies seeking a more codified, statutory model of corporate governance, say attorneys at Bracewell.
-
Series
Law School's Missed Lessons: Communicating With Clients
Law school curricula often overlook client communication procedures, and those who actively teach this crucial facet of the practice can create exceptional client satisfaction and success, says Patrick Hanson at Wiggam Law.
-
Series
Adapting To Private Practice: From US Rep. To Boutique Firm
My transition from serving as a member of Congress to becoming a partner at a boutique firm has been remarkably smooth, in part because I never stopped exercising my legal muscles, maintained relationships with my former colleagues and set the right tone at the outset, says Mondaire Jones at Friedman Kaplan.
-
Spinoff Transaction Considerations For Biotech M&A
Amid current market challenges, boards and management teams of biotech companies can consider several strategies for maximizing value should a spinoff opportunity arise, but not without significant advance planning and careful implementation, particularly in cases that might qualify as tax-free, say attorneys at Paul Hastings.
-
Opinion
Senate's 41% Litigation Finance Tax Would Hurt Legal System
The Senate’s latest version of the Big Beautiful Bill Act would impose a 41% tax on the litigation finance industry, but the tax is totally disconnected from the concerns it purports to address, and it would set the country back to a time when small plaintiffs had little recourse against big defendants, says Anthony Sebok at Cardozo School of Law.
-
Series
Performing As A Clown Makes Me A Better Lawyer
To say that being a clown in the Macy’s Thanksgiving Day Parade has changed my legal career would truly be an understatement — by creating an opening to converse on a unique topic, it has allowed me to connect with clients, counsel and even judges on a deeper level, says Charles Tatelbaum at Tripp Scott.
-
Series
Law School's Missed Lessons: Rejecting Biz Dev Myths
Law schools don’t spend sufficient time dispelling certain myths that prevent young lawyers from exploring new business opportunities, but by dismissing these misguided beliefs, even an introverted first-year associate with a small network of contacts can find long-term success, says Ronald Levine at Herrick Feinstein.
-
Del. Dispatch: General Partner Discretion In Valuing Incentives
In Walker v. FRP Investors, the Delaware Court of Chancery recently held that the general partner of a limited partnership breached its obligations when determining the threshold value of newly issued incentive units, highlighting the court's willingness to reconstruct what a reasonable determination of value by a general partner should have been, say attorneys at Fried Frank.
-
Move Beyond Surface-Level Edits To Master Legal Writing
Recent instances in which attorneys filed briefs containing artificial intelligence hallucinations offer a stark reminder that effective revision isn’t just about superficial details like grammar — it requires attorneys to critically engage with their writing and analyze their rhetorical choices, says Ivy Grey at WordRake.
-
How Ore. Law Puts New Confines On Corp. Health Ownership
A newly enacted law in Oregon strengthens the state’s restrictions on corporate ownership of healthcare practices, with new limitations on overlapping control, permissible services, restrictive covenants and more making it necessary for practices to review decades-old physician practice arrangements, say attorneys at Ropes & Gray.
-
Observations On 5 Years Of Non-Notified CFIUS Inquiries
Since 2020, the Committee on Foreign Investment in the United States has identified and investigated covered cross-border transactions not formally notified to CFIUS, and a look at data from 50 non-notified matters during that time reveals the general dynamics of this enforcement function, say attorneys at Cooley.
-
9th Circ. Has Muddied Waters Of Article III Pleading Standard
District courts in the Ninth Circuit continue to apply a defunct and especially forgiving pleading standard to questions of Article III standing, and the circuit court itself has only perpetuated this confusion — making it an attractive forum for disputes that have no rightful place in federal court, say attorneys at Gibson Dunn.
-
Trump Antitrust Shift Eases Pressure On Private Equity Deals
Enforcement actions and statements by Trump administration antitrust officials forecast a shift away from specifically targeting private equity activity, which should be welcome news to dealmakers, but firms shouldn't expect to escape traditional antitrust scrutiny, says Nathaniel Bronstein at Fried Frank.
-
Series
Competing In Modern Pentathlon Makes Me A Better Lawyer
Opening myself up to new experiences through competing in modern Olympic pentathlon has shrunk the appearance of my daily work annoyances and helps me improve my patience, manage crises better and remember that acquiring new skills requires working through your early mistakes, says attorney Mary Zoldak.